S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
Log in

NASDAQ:AKTS - Akoustis Technologies Stock Price, Forecast & News

$8.87
+0.04 (+0.45 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$8.67
Now: $8.87
$8.93
50-Day Range
$7.51
MA: $8.09
$8.96
52-Week Range
$5.17
Now: $8.87
$9.25
Volume240,439 shs
Average Volume336,995 shs
Market Capitalization$320.77 million
P/E RatioN/A
Dividend YieldN/A
Beta0.67
Akoustis Technologies, Inc, through its subsidiary, Akoustis, Inc, develops, designs, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industries in the United States. The company operates through two segments, Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment provides engineering review services; and smart systems technology and commercialization center foundry, as well as manufacturing and microelectromechanical systems foundry services. Read More…

Industry, Sector and Symbol

Industry Telephone & telegraph apparatus
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:AKTS
CUSIPN/A
Phone704-997-5735

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.44 million
Book Value$0.87 per share

Profitability

Net Income$-29,250,000.00
Net Margins-1,843.77%

Miscellaneous

Employees69
Market Cap$320.77 million
Next Earnings Date2/3/2020 (Estimated)
OptionableNot Optionable

Receive AKTS News and Ratings via Email

Sign-up to receive the latest news and ratings for AKTS and its competitors with MarketBeat's FREE daily newsletter.


#1 Futurist Says: Get Ready for This Global "Reboot" (Ad)


George Gilder has a shocking message for anybody with money in the bank, with a job that pays in dollars, or who carries a smartphone in their pocket. "Brace yourself," he says, "for the coming $16.8 trillion global 'reboot' ahead." It could change the way you get paid...change the way you save and invest for retirement.

Akoustis Technologies (NASDAQ:AKTS) Frequently Asked Questions

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies Inc (NASDAQ:AKTS) posted its quarterly earnings data on Thursday, November, 7th. The technology company reported ($0.30) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.23) by $0.07. The technology company earned $0.54 million during the quarter, compared to the consensus estimate of $0.59 million. Akoustis Technologies had a negative return on equity of 105.40% and a negative net margin of 1,843.77%. View Akoustis Technologies' Earnings History.

When is Akoustis Technologies' next earnings date?

Akoustis Technologies is scheduled to release their next quarterly earnings announcement on Monday, February 3rd 2020. View Earnings Estimates for Akoustis Technologies.

What price target have analysts set for AKTS?

4 brokers have issued 1 year price objectives for Akoustis Technologies' stock. Their forecasts range from $7.00 to $12.00. On average, they anticipate Akoustis Technologies' share price to reach $10.00 in the next year. This suggests a possible upside of 12.6% from the stock's current price. View Analyst Price Targets for Akoustis Technologies.

What is the consensus analysts' recommendation for Akoustis Technologies?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Akoustis Technologies.

Has Akoustis Technologies been receiving favorable news coverage?

Media headlines about AKTS stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Akoustis Technologies earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Akoustis Technologies.

Who are some of Akoustis Technologies' key competitors?

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Verizon Communications (VZ), Advanced Micro Devices (AMD), Crispr Therapeutics (CRSP), NVIDIA (NVDA), Editas Medicine (EDIT), Skyworks Solutions (SWKS), Micron Technology (MU), QUALCOMM (QCOM), Smart Global (SGH) and Alibaba Group (BABA).

Who are Akoustis Technologies' key executives?

Akoustis Technologies' management team includes the folowing people:
  • Mr. Jeffrey B. Shealy, Founder,Pres, CEO & Director (Age 50)
  • Mr. David M. Aichele, VP of Bus. Devel. (Age 53)
  • Mr. Kenneth Boller, Interim Chief Financial Officer
  • Mr. Thomas Andrew Sepenzis, Director of Investor Relations (Age 47)
  • Mr. Drew Wright, Gen. Counsel & Corp. Sec.

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Eidelman Virant Capital (0.14%) and Endurance Wealth Management Inc. (0.02%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, John T Kurtzweil, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy. View Institutional Ownership Trends for Akoustis Technologies.

Which major investors are buying Akoustis Technologies stock?

AKTS stock was purchased by a variety of institutional investors in the last quarter, including Eidelman Virant Capital and Endurance Wealth Management Inc.. View Insider Buying and Selling for Akoustis Technologies.

How do I buy shares of Akoustis Technologies?

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $8.88.

How big of a company is Akoustis Technologies?

Akoustis Technologies has a market capitalization of $321.13 million and generates $1.44 million in revenue each year. Akoustis Technologies employs 69 workers across the globe.View Additional Information About Akoustis Technologies.

What is Akoustis Technologies' official website?

The official website for Akoustis Technologies is http://www.akoustis.com/.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]


MarketBeat Community Rating for Akoustis Technologies (NASDAQ AKTS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  189 (Vote Outperform)
Underperform Votes:  184 (Vote Underperform)
Total Votes:  373
MarketBeat's community ratings are surveys of what our community members think about Akoustis Technologies and other stocks. Vote "Outperform" if you believe AKTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AKTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Featured Article: Asset Allocation

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel